EE232 Cost-Effectiveness of a Genomic Profiling Test for HRD Determination in Ovarian Cancer Into the Current Clinical Practice for Platinum-Sensitive Patients With Advanced Ovarian Cancer in Greece
Abstract
Authors
K. Zisis N. Nomikos P. Naoum G. Agorastos K. Athanasakis